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Object. To determine if tetracycline, previously reported to increase the probability of developing symptomatic vaginal yeast
infections, has a direct eﬀect on Candida albicans growth or induction of virulent phenotypes. Method. In vitro, clinical isolates
of yeast were cultivated with sublethal concentrations of tetracycline and yeast cell counts, hyphal formation, drug eﬄux pump
activity, bioﬁlm production, and hemolysin production were determined by previously reported methods. Results. Tetracycline
concentrations above 150μg/mL inhibited Candida albicans, but at submicrogram/mL, a modest growth increase during the
early hours of the growth curve was observed. Tetracycline did not inhibit hyphal formation at sublethal concentrations. Hypha
formation appeared augmented by exposure to tetracycline in the presence of chemically deﬁned medium and especially in the
presenceofhumanserum.EﬄuxpumpCDR1wasupregulatedandanonsigniﬁcanttrendtowardincreasedbioﬁlmformationwas
noted.Conclusion.Tetracyclineappearstohaveasmallgrowthenhancingeﬀectandmayinﬂuencevirulencethroughaugmentation
of hypha formation, and a modest eﬀect on drug eﬄux and bioﬁlm formation, although tetracycline did not aﬀect hemolysin. It
is not clear if the magnitude of the eﬀect is suﬃcient to attribute vaginitis following tetracycline treatment to direct action of
tetracycline on yeast.
Copyright © 2008 Logan McCool et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Epidemiological studies purport that the use of certain
antibiotics during pregnancy increases susceptibility to
vulvo-vaginal candidiasis [1, 2]. This condition is generally
believed to result from the suppression of a bacterial ﬂora in
the face of antibacterial drugs that fail to inhibit Candida,
resulting in its overgrowth and subsequent emergence of
symptoms. Although this concept is often repeated in
textbooks, surprisingly little direct evidence exists to support
the concept that vaginal candidiasis is caused by prior
antibiotic treatment. A report by Burns et al. [3]p r o v i d e d
correlation between antibiotic use and vaginal colonization
and candidiasis. Since the role of antibiotics in eliciting yeast
vaginitis is medical dogma, there has been little reason to
expend eﬀort on developing actual data on the relationship
between antibiotics and candidiasis.
In 1998, Glover and Larsen [4], curious about the
magnitude of the impact of antibiotics on yeast vaginitis,
unexpectedly found that nonantibiotic-treated pregnant
patients actually became symptomatic more frequently than
did the patients treated with antibiotics. This prompted
a search in the literature for evidence of a direct eﬀect
of antibiotic treatment on yeast colonization. The clearest
evidence for antibiotic eﬀects on yeast colonization came
from the paper by Caruso [1] who implicated tetracycline as
increasing yeast vaginal colonization. Tetracycline was also
implicated by Oriel and Waterworth [5] who indicated that
14 days of tetracycline or minocycline treatment increased
vaginal Candida culture positive rate from 13% to 29%.
Although tetracycline was not employed in Glover and
Larsen’s analysis [4] because their study focused on pregnant
women, they did speculate that tetracycline may have had
some direct eﬀect on Candida independent of its eﬀect on
competing vaginal bacterial ﬂora. Previous studies showed
that estradiol and other drugs were able to aﬀect the
growth of Candida and the expression of certain virulence-
related factors [6, 7], implying that a variety of chemical
compounds including tetracycline, may exert a direct eﬀect
on Candida apart from or in addition to its antimicrobial
activity. It is against this background that we investigated
whether tetracycline may have direct eﬀects on the growth
or expression of virulence attributes of Candida albicans.
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of antibiotics, particularly tetracycline, and candidiasis that
is distinct from the antimicrobial eﬀect on the normal ﬂora.
2. MATERIALS AND METHODS
Human isolates of Candida albicans were available in our
laboratory culture collection. These were originally obtained
from gynecologic specimens and identiﬁed as C. albicans by
observing microscopic morphology, germ-tube formation in
human serum, and production of brown colonies on BIGGY
agar. Candida were maintained at −80◦C, and when needed,
revived on Sabouraud’s Dextrose Agar and held at 4◦C until
use in a speciﬁc experiment. Prior to any experiment, the
organisms were removed from the refrigerated plate culture
and subcultured in an appropriate liquid medium to create
an actively-growing starter culture.
Six human isolates of C. albicans were used. Three of
these had previously been shown to have growth stimulation
in the presence of estrogen (GT 387, GT 142, GT 397) and
the other three showed restricted growth in the presence
of estrogen (GT 188, GT 132, 986). In addition, a special
indicator organism, CaSA1 [8] which has a green ﬂuorescent
protein gene inserted in place of one allele of the CDR1
structural gene, was used to investigate regulation of CDR1.
This gene encodes an ATP binding cassette molecular pump
that confers multidrug resistance on the organism and
is upregulated both by azole antifungal drugs as well as
estradiol [9].
Growth yield studies were performed by diluting an
overnight starter culture prepared in Yeast Nitrogen Broth
with 0.5% glucose (YNB), and the culture was diluted 104-
fold in fresh YNB with and without additives at ﬁnal concen-
trations as described in the individual experiments. Experi-
ments employed tetracycline or estrogen (1, 3, 5[10]-estra-
triene-3, 17β-diol, referred to hereafter as 17β-estradiol)
as additives in the growth experiments. 17β-estradiol was
employed as a positive control in some experiments since
we knew from prior studies what eﬀect this compound had
on the test strains used. When experimental cultures were
prepared, they were incubated overnight at 30◦Co r3 7 ◦C
beforecountsweremadebyhemacytometer.Forconsistency,
hyphal forms were counted on the basis of the presumed
number of nuclei visualized. Budding cells were counted as 2
when a constriction at the bud neck had formed between the
mother and daughter cells. While overnight growth in YNB
did produce some hyphal forms, they were not predominant
and contributed little to the overall counts performed by
hemacytometer. For growth-rate determination, overnight
starter cultures were diluted ten folds into fresh medium and
grown for approximately 2 hours to ensure the culture we
note in stationary phase of growth.
Evaluation of germination in Candida was performed by
making a heavy suspension of the test organism in serum
or YNB, with or without tetracycline and incubating at
37◦C for 30 minutes and 3 hours. Cells are examined at
each time point and presence or absence of germ tubes
determined by microscopic examination at 100x and 400x.
Video microscopy was available to compare images obtained
from diﬀerent culture conditions.
Induction of the CDR-1 gene under various growth
conditions was analyzed by ﬂow cytometry in the green
ﬂuorescence channel (FL1) as described in our previous
studies [8]. Data were normalized in relation to control
values, and ﬂuorescence of treated cells was reported as
fold-increase-over control (FIOC). Previous work from our
laboratory sought to determine if germinated or hyphal cells
provided a stronger ﬂuorescent signal than yeast cells. If
the instrument is gated on higher forward scatter values,
we found that mean channel ﬂuorescence for high forward
scatter particles did not contribute disproportionately to the
mean channel ﬂuorescence of the population.
Inductionofbioﬁlmformationwasmeasuredbycreating
bioﬁlm on the bottoms of ﬂat-well microtiter plates. Brieﬂy,
overnight cultures of the selected test strains of Candida
were grown in unsupplemented growth media or in media
supplemented with 17β-estradiol or tetracycline at 30◦Co r
37◦C. Starter cultures of selected yeast strains were diluted
10
−4-fold and allowed to adhere to well bottoms for 1 hour
after which all wells were vigorously washed with a plate
washer to remove unbound yeast. Media with or without
test additives was replaced in the wells, and bioﬁlm was
allowed to develop through overnight incubation at 37◦C.
At the conclusion of bioﬁlm development, the wells again
were exhaustively washed and overlaid with 100μLo f0 . 5 %
glucose and 5μL of Alimar Blue metabolic indicator. Plates
were read spectrophometrically at 30 minute intervals for
2 hours, and the area under the time—absorbance600 curve
(AUC) was taken as an indication of the amount of biomass
adherent to the wells.
Hemolysin production was measured by exposing super-
natantsofspentCandidaculturestoa1%humanerythrocyte
suspension in phosphate buﬀered saline, removing unlysed
erythrocytes by centrifugation and reading the hemoglobin




The ﬁrst question addressed by this study was whether
tetracyclinecouldincreasefungalgrowth,sincedirectgrowth
enhancement could explain why prior studies reported
increased yeast colonization after tetracycline therapy. To
establish whether any concentration of tetracycline altered
growth of Candida albicans strains, various concentrations
were tested for their eﬀects on overnight growth; concen-
trations of tetracycline between 5 and 0.15mg/mL were
inhibitory toward Candida albicans with 5mg/mL reducing
hemacytometer counts to near zero and 150μg/mL reducing
counts by half compared to the control containing no
tetracycline. While hemacytometer counts were useful in
distinguishing the obvious diﬀerence between tetracycline-
treated and control cultures at high tetracycline level, we
turned to viable plate counts to elucidate more subtle diﬀer-
ences in growth of yeast exposed to sublethal concentrations
of the drug. In at least three separate trials with duplicate
plate counts (not hemacytometer) determinations, the eﬀectLogan McCool et al. 3
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Figure 1: The eﬀect of adding a very low concentration of
tetracycline to chemically deﬁned growth medium (YNB) on
overnight viable counts of 6 strains of yeast is shown. Three strains
of yeast (GT188, 986, and GT132) were previously known to be
nonsensitive to 17β-estradiol (did not show increased growth yield
in the presence of 1 × 10
−5 M/L 17β-estradiol), and 3 strains
(GT387, 397, and GT142) were previously shown to be sensitive to
growth yield stimulation in the presence of 17β-estradiol. Standard
deviations from triplicate determinations are shown by error bars.
White bars represent growth in YNB, and black bars represent
growth in YNB with 0.1μg/mL tetracycline.
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of 0.1 and 0.3μg/mL proved variable with tetracycline-
containing cultures having from 54–126% of control counts.
Those organisms previously shown to be stimulated by 17β-
estradiol showed an insigniﬁcant growth increment in the
presence of tetracycline, whereas those not stimulated by
estrogen did not show increased growth. The magnitude of
this tendency was not suﬃcient to draw ﬁrm conclusions
about possible growth stimulation by tetracycline (Figure 1).
Because antibiotics may cause ﬁtness-enhancing gener-
alized stress responses at sublethal concentrations and stress
responses may be induced rapidly, we also examined viable
plate counts at 6 hours in lieu of overnight growth for strain
142.Tetracyclineconcentrationsfrom0.3–5μg/mLincreased
counts by as much as four folds (Table 1) indicating an eﬀect
on growth may be transient but apparently not sustained
long enough to produce signiﬁcantly more growth after
overnight culture.
3.2. Yeastgermination
The ability of Candida albicans to form germ tubes, pseudo-
hyphae, or hyphae is considered an expression of the more
virulent forms of the organism. We tested several strains of
yeast initially with 0.3μg/mL of tetracycline in liquid media
and human serum to determine if tetracycline altered hyphal
production. YNB, a chemically-deﬁned medium, showed the
presence of many germ tubes after 3 hours incubation at
37◦C, and in human serum, even more extensive germ-tube
formation was seen. We were unable to discern an eﬀect of
tetracycline on germination in either YNB or serum. These
cultures were held at 37◦C overnight and viewed again. In
YNB, there were mostly yeast forms and a substantial num-
ber of pseudohyphae, and a similar morphologic appearance
was found among tetracycline-treated YNB cultures. In
contrast, culture in serum caused Candida transformation
to mostly hyphal growth. It was clear that tetracycline did
not interfere with hyphal formation at 0.3μg/mL and may
have enhanced hyphal formation. To investigate this further,
we tested additional concentrations of tetracycline (1, 3,
and 5μg/mL) and found that at 5μg/mL it was possible
to obtain evidence that in both YNB (Figure 2) and in
serum (Figure 3) tetracycline seemed to enhance hyphal
formation. The eﬀect was particularly profound when serum
was present, a condition possibly more representative of
conditions that prevail in vivo.
3.3. RegulationofCDR1
In addition to eﬀects on growth, tetracycline might alter
the expression of virulence factors related to colonization
and symptoms in antibiotic-treated patients. The drug
eﬄux pump CDR1 has been shown to be promiscuously
upregulated by 17β-estradiol and coumarin and may be
part of a generalized stress response that enhances ﬁtness of
Candida [8]. With the availability of the CaSA1 organism
[8], we were able to examine the eﬀect of tetracycline on
CDR1 expression. The eﬀect on CDR1 expression was tested
by incubation of CaSA 1 with or without tetracycline at 0.1,
0.3, 5, and 10μg/mL after overnight incubation at 37◦C.
Flow cytometry was used to determine the relative amount
of GFP produced and the known inducer of CDR1 ;1 7 β-
estradiol (at 1 × 10
−5 M) was used as a positive control.
The maximum increase caused by tetracycline was only a
30% increase relative to negative controls (Table 2). This
level of induction was signiﬁcant (p = 0.05, unpaired 2-
tailed t-test) when compared to the unstimulated CaSA 1
organism but was unremarkable compared to the known
inducer,estradiol(p = 0.0004,2-tailedunpairedt-testversus
CaSA 1), especially in view of the fact that the highest molar
concentration tetracycline was greater than that of estradiol.
3.4. Bioﬁlm
Bioﬁlmisincreasinglybeingrecognizedasanimportantcon-
tributor to pathogenesis by mucosal organisms. The poten-
tial for tetracycline to alter the bioﬁlm production under in









Figure 2: Photomicrographs of Candida albicans (Strain GT142) grown overnight at 37◦C in YNB or YNB plus tetracycline (5μg/mL). The
yeast tended toward germination and ﬁlamentation in YNB, and tetracycline did not inhibit this tendency. Images are representative of many










Figure 3: Photomicrographs of Candida albicans (Strain GT142) grown overnight at 37◦C in serum or serum plus tetracycline (5μg/mL).
The tendency of tetracycline to enhance ﬁlamentous growth is particularly evident in the right-hand panel.
a role of tetracycline in enhancing symptomatic vulvovaginal
candidiasis. As illustrated in Figure 4, overnight culture in
the presence of tetracycline was not unequivocally associated
with increased production of bioﬁlm at 37◦C, although a
slight, though not statistically diﬀerent, increase in bioﬁlm
metabolicactivitywasnotedfor5of6Candidastrainstested.
It was clear that this biological assay was characterized by
substantialvariabilityasseenbythewidestandarddeviations
and perhaps with a reﬁned method, the tendency toward
bioﬁlm formation in the presence of tetracycline could be
conﬁrmed.Inparallelwiththisstudy,theeﬀectofnanomolar
estradiol induced a nonsigniﬁcant trend toward increased
level of bioﬁlm activity (data not shown) at 37◦Ca n da s
such provided data that appeared very similar to tetracycline
exposure.
3.5. Hemolysin
The ﬁnal potential virulence property evaluated in this study
was Candida albicans was hemolysin which may aid the
organism in acquiring iron in vivo. Hemolytic activity in
s p e n tc u l t u r e so fCandida is typically consistently detected,
but the magnitude of eﬀect is relatively low amounting to
less than 5% hemolysis of a 1% erythrocyte suspension in
30 minutes. Hemolytic activity is summarized in Figure 5
and shows that baseline hemolytic activity (in the absence
of tetracycline or estradiol) varied with strain, and mini-
mal eﬀect was observed when tetracycline (0.1μg/mL), or
nanomolar estradiol was added to the growth medium.
Higherconcentrationsoftetracyclinedidnotappeartoaﬀect
the hemolytic activity of spent cultures.
4. DISCUSSION
This study focused on the possibility that growth of Candida
albicans and the expression of virulence attributes may
be altered by the exposure of this fungal pathogen to
tetracycline. A long-standing medical dogma states that
antibiotic therapy is often accompanied by development of
symptomatic yeast vaginitis, though in a study we conducted
during pregnancy we found that antibiotics other than
tetracyclinedidnotpromoteyeastvaginitis.Becauseanolder
study of tetracycline [1] linked prolonged treatment with
increasing rates of vaginal yeast colonization, we intended
to look for direct eﬀects of tetracycline on yeast growth and
virulence attribute expression.Logan McCool et al. 5
Table 2: Flow cytometry evaluation of CDR1 expression in response tetracycline exposure.
Condition Fl-1hour (mean channel ﬂuorescence) FIOC (fold increase over control ﬂuorescence)
CaSA1 (organism background) 5.07 ±0.88 1.0
Estradiol (positive control) 34.56 ± 4.27 6.86 ±0.39
10μg/mL tetracycline 6.52 ±0.26 1.31 ±0.23
5μg/mL tetracycline 5.54 ±0.79 1.10 ±0.13
0.3μg/mL tetracycline 4.12 ±0.25 0.84 ±0.19
0.1μg/mL tetracycline 3.77 ±0.11 0.76 ±0.13
Candida albicans strains








































Figure 4: Bioﬁlm was produced in the YNB growth media with
or without the addition of tetracycline (0.1μg/mL). Bioﬁlm was
measured by allowing the metabolic indicator Alimar Blue to be
reduced by the biomass remaining after vigorous washing of the
wells. The relative bioﬁlm measure represents the dye reduction
over a 2-hour period measured at 600 nm spectrophotometrically.
Ofnote,5ofthe6strainstestedshowedatendencytowardincreased
bioﬁlm metabolic activity when exposed to tetracycline, though
the variability of the biological assay limited deﬁnite conclusions
regarding excess bioﬁlm production.
Candida albicans strains
























Figure 5: Very little hemolytic activity was detected in cultures of
Candida albicans regardless of the presence or absence of added
tetracycline (0.1μg/mL). The greatest amount f hemolysis detected
was 4% lysis of a 1% erythrocyte suspension. As shown by the
ﬁgure, there was minimal diﬀerence between strains employed
in this evaluation. It may be concluded that tetracycline has a
negligible eﬀect on hemolytic activity of Candida.
Tetracycline, like 17 ß-estradiol, has a phenolic A ring,
althoughthehydroxylgroupintetracyclineisinthe2instead
of 3 position as it is in estradiol. Nevertheless, our previous
ﬁnding that 17 ß-estradiol at concentrations ranging from
1 × 10
−5 to 1 × 10
−9 M/L increases Candida growth in some
strains, and certain virulence attributes are elevated by 17
ß-estradiol, encouraged the current study since it was not
clear precisely what chemical signature accounted for some
of the previously observed direct eﬀects of 17 ß-estradiol on
yeast including growth stimulation and upregulation of drug
eﬄux mechanisms.
B e c a u s em a n yb i o l o g i c a le ﬀects of 17β-estradiol have
been observed in Candida albicans [6–11], we reasoned that
tetracycline may have chemical similarities that could elicit
similar direct eﬀects on the organism such as increasing
growth or upregulating virulence factors. These biological
eﬀects could help explain the role of tetracycline in symp-
tomatic yeast vaginitis in a manner that goes beyond the
medical dogma that attributes vaginal infection to bacterial
killing and simultaneous fungal sparing. However, tetracy-
cline does appear to have antifungal activity, at least when
present in high concentration as noted in the present study,
raisingnewquestionsaboutoldbeliefsaboutpathogenesisof
vaginal candidiasis.
After submitting the present manuscript we became
aware that White’s group published an important study [12]
that indicated that tetracycline was inhibitory toward Can-
dida, Cryptococcus,a n dAspergillus. However, their research
focused on in vitro tetracycline concentrations that were 1-
2 orders of magnitude larger than the levels investigated in
this paper. Still, it is important to realize that tetracycline,
while not used as an antifungal drug, does have inhibitory
properties that are dose related.
In the current study, we focused on tetracycline con-
centrations in the range of 0.1–10μg/mL (2.1 × 10
−7 M
to 2.1 × 10
−5 M) which is in the range of typical serum
concentrations among individuals being treated [13]. At
higher concentrations (3–5mg/mL), tetracycline proved to
be antibiotic toward Candida albicans, particularly when
the yeast strains were cultivated overnight with the drug.
A slight increase in growth was obtained with incubation
times shorter than overnight with submicrogram/mL con-
centrations among some, but not all, yeast strains. Moreover,
the magnitude of growth increases was quite small and not
suﬃcient to support the hypothesis that growth stimulation
by tetracycline was the likely mechanism predisposing to
yeast vaginitis. We noted that the tendency of growth eﬀects
of tetracycline seemed to mirror those we had previously6 Infectious Diseases in Obstetrics and Gynecology
seen for estradiol, underscoring our belief that as a chemical
entity, tetracycline might have some biological eﬀects similar
to estradiol. These growth studies may deserve additional
evaluation in the future.
Although preliminary growth studies suggested that
Candida albicans, like bacteria, may be adversely aﬀected
by high levels of tetracycline, and the small magnitude
of growth stimulation at low concentrations makes direct
growthstimulationanunlikelysoleexplanationforincreased
vaginitis among tetracycline treated women. However, a
growth increment coupled with elevated virulence of yeast
oﬀers a potential explanation for tetracycline promotion of
symptomatic yeast infection.
Four-virulence attributes were studied mainly at the
phenotypic level and appeared to be aﬀected variously by
exposure of the yeast to tetracycline. Most striking among
these was the ﬁnding that germination and related transition
from yeast to hyphal growth were augmented in the presence
of tetracycline, and this was especially true when serum
was present. This ﬁnding has practical relevance to the
potential eﬀects of tetracycline in vivo because the hyphal
form of the organism is reputed to be its most virulent state.
Had this study indicated that tetracycline prevents hyphal
transformationinsteadofaugmentingit,itwouldbediﬃcult
to suggest how tetracycline treatment might contribute to
yeast vaginitis.
For sometime, we have hypothesized that the drug
eﬄux pump CDR1 may serve the organism to enhance its
ﬁtness in hostile environments [11]. To examine the eﬀect
of tetracycline on CDR1 expression, a special recombinant
indicator strain was employed which explains why this
experiment did not involve the panel of test organisms used
in the remainder of the study. The yeast CaSA1 produces
green ﬂuorescent protein in response to azole drugs and
exposure to estradiol [8]; and when sublethal concentrations
of tetracycline were introduced to cultures of CaSA1, it
was found that a slight (30%) increase in ﬂuorescence
occurred at 37◦Ca t1 0 μg/mL, but not at lower levels.
In the recent study from White’s group [12], they failed
to ﬁnd upregulation of CDR1 at the levels of tetracycline
they employed. Higher levels of tetracycline are likely to
suppressproteinsynthesisassuggestedbyourgrowthstudies
CDR1 expression that was not studied at concentrations
of tetracycline that inhibited fungal growth. Because CDR1
expression appears to be adaptive under adverse conditions,
this factor could incrementally help the yeast to survive
under hostile conditions; although as demonstrated by our
positive controls, the upregulation of CDR1 in the presence
of tetracycline was far below levels attained with equimolar
levels of estradiol (5μg/mL tetracycline was approximately
equal to the molarity of the estradiol positive control).
The virulence attributes of bioﬁlm and hemolysin pro-
duction were also examined, and there was a tendency
toward increased bioﬁlm formation which, though not
signiﬁcant in magnitude, was at least fairly consistent across
test strains evaluated. There was clearly a notable degree of
variability (see Figure 4) among replicate tests for bioﬁlm
production, but because it was a biological rather than
strictly analytical method, the variability was not surprising,
but did undermine our ability to unequivocally demonstrate
tetracycline as a stimulant of bioﬁlm.
Hemolysin, as shown by Figure 5 which in Candida,i s
poorly characterized, tended to be slightly increased in the
presence of tetracycline, but the eﬀect was modest and
consequently unlikely to have biological signiﬁcance. It is
diﬃcult to claim with certainty from this study that any
tendency of women to develop vaginitis symptoms after
tetracycline therapy is due to direct eﬀects of the drug on
bioﬁlm or hemolysin, but the slight eﬀects on early growth
a n dm o r ep r o f o u n de ﬀects on hyphal formation could
contribute to yeast vaginitis.
It is worth noting that a plethora of genes in Candida
have been identiﬁed as having an association with virulence.
This list is large and continues to grow, but importantly
available molecular methods for analysis of expression of
virulence genes could be applied to Candida exposed to
tetracycline.Wehavenotyetdelvedintostudiesofexpression
of these speciﬁc genes because we preferred in this prelim-
inary work, to establish a suﬃcient biological cause on a
phenotypic level to warrant additional studies of putative
virulence genes.
We conclude from this investigation that tetracycline,
though displaying an antifungal eﬀect at high concentra-
tions, has a small be detectable stimulating eﬀect on growth
rate at sublethal concentrations. This eﬀect in conjunction
with the more potent is the eﬀect of tetracycline on hyphal
morphogenesis, and possible enhancement of bioﬁlm for-
mation may contribute to the tetracycline’s relationship
to symptomatic yeast vaginitis. While not unequivocally
demonstrating that tetracycline aﬀects Candida and thereby
predisposing to vaginitis, it does suggest that future research
should pursue this hypothesis.
Finally, we return to the medical dogma that prompted
this report. The concept that vaginal symptoms developing
after tetracycline therapy is merely the result of reduction
in bacterial populations with a simple overgrowth of yeast is
commonly repeated. This explanation, in light of the current
study, appears too simplistic as high levels of tetracycline
inhibit Candida which should reduce the risk of vaginitis,
but antifungal concentrations may not be attainable with
typical doses. In contrast, sublethal concentrations appear
to aﬀect the physiology of the yeast in a way consistent
with predisposition to symptomatic yeast vaginitis which
may modify the view of pathogenesis of vaginitis following
tetracycline treatment.
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